Global Targeted Sequencing Market to Reach $10.97 Billion by 2032 – Exclusive DeepTech M-A-PTM Analysis by BIS Research

The major advantage of targeted sequencing as compared to whole genome sequencing is the smaller and more manageable data sets created, which are significantly easier to analyze. FREMONT, Calif., Feb. 23, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market...

Click to view original post